Indolequinone-rhodol conjugate as a fluorescent probe for hypoxic cells: enzymatic activation and fluorescence properties

被引:66
作者
Komatsu, Hirokazu [1 ,2 ]
Harada, Hiroshi [3 ]
Tanabe, Kazuhito [1 ]
Hiraoka, Masahiro [4 ]
Nishimoto, Sei-ichi [1 ]
机构
[1] Kyoto Univ, Dept Energy & Hydrocarbon Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan
[2] ASTEM, Kyoto City Collaborat Reg Entities Advancement Te, Kyoto 6158510, Japan
[3] Kyoto Univ, Grp Radiat & Tumor Biol, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Kyoto 6068501, Japan
[4] Kyoto Univ, Dept Radiat Oncol & Image Appl Therapy, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan
关键词
HETEROCYCLIC SIDE-CHAINS; BIOLOGICAL EVALUATION; BIOREDUCTIVE BINDING; ANTITUMOR AGENTS; SOLID TUMOR; MARKERS; ELIMINATION; DERIVATIVES; PRODRUGS; SENSORS;
D O I
10.1039/c0md00024h
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypoxia is an important feature of many diseases such as malignant solid tumors, inflammatory diseases and cardiac ischemia. We herein focused on the development of a novel hypoxia-sensitive fluorescent probe, IQ-R, consisting of an indolequinone unit and a rhodol fluorophore. IQ-R has good solubility in water and longer wavelength for absorption and emission, which are favorable for cellular bioimaging. While the fluorescence of rhodol in the IQ-R conjugate was quenched by the function of intramolecular indolequinone unit, it was restored under hypoxic conditions through the enzymatic one-electron reduction of IQ-R by NADPH:cytochrome P450 reductase to release the nonconjugated free rhodol. When administered to A549 cells, IQ-R was activated and reduced by endogenous reductase preferentially under hypoxic conditions, thereby visualizing hypoxic cancer cells by robust fluorescence.
引用
收藏
页码:50 / 53
页数:4
相关论文
共 27 条
[1]   Signaling recognition events with fluorescent sensors and switches [J].
de Silva, AP ;
Gunaratne, HQN ;
Gunnlaugsson, T ;
Huxley, AJM ;
McCoy, CP ;
Rademacher, JT ;
Rice, TE .
CHEMICAL REVIEWS, 1997, 97 (05) :1515-1566
[2]   Synthetic fluorescent sensors for studying the cell biology of metals [J].
Domaille, Dylan W. ;
Que, Emily L. ;
Chang, Christopher J. .
NATURE CHEMICAL BIOLOGY, 2008, 4 (03) :168-175
[3]   Modifying rates of reductive elimination of leaving groups from indolequinone prodrugs: a key factor in controlling hypoxia-selective drug release [J].
Everett, SA ;
Swann, E ;
Naylor, MA ;
Stratford, MRL ;
Patel, KB ;
Tian, N ;
Newman, RG ;
Vojnovic, B ;
Moody, CJ ;
Wardman, P .
BIOCHEMICAL PHARMACOLOGY, 2002, 63 (09) :1629-1639
[4]   Fluorescence molecular imaging of small animal tumor models [J].
Graves, EE ;
Weissleder, R ;
Ntziachristos, V .
CURRENT MOLECULAR MEDICINE, 2004, 4 (04) :419-430
[5]   Hypoxia - A key regulatory factor in tumour growth [J].
Harris, AL .
NATURE REVIEWS CANCER, 2002, 2 (01) :38-47
[6]   Design, synthesis, and biological evaluation of indolequinone phosphoramidate prodrugs targeted to DT-diaphorase [J].
Hernick, M ;
Flader, C ;
Borch, RF .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (16) :3540-3548
[7]   FLUORESCENT MARKERS FOR HYPOXIC CELLS - A STUDY OF NITROAROMATIC COMPOUNDS, WITH FLUORESCENT HETEROCYCLIC SIDE-CHAINS, THAT UNDERGO BIOREDUCTIVE BINDING [J].
HODGKISS, RJ ;
JONES, GW ;
LONG, A ;
MIDDLETON, RW ;
PARRICK, J ;
STRATFORD, MRL ;
WARDMAN, P ;
WILSON, GD .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (07) :2268-2274
[8]   BIOREDUCTIVE FLUORESCENT MARKERS FOR HYPOXIC CELLS - A STUDY OF 2-NITROIMIDAZOLES WITH 1-SUBSTITUENTS CONTAINING FLUORESCENT, BRIDGEHEAD-NITROGEN, BICYCLIC SYSTEMS [J].
HODGKISS, RJ ;
MIDDLETON, RW ;
PARRICK, J ;
RAMI, HK ;
WARDMAN, P ;
WILSON, GD .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (10) :1920-1926
[9]   Tumor hypoxia: A target for selective cancer therapy [J].
Kizaka-Kondoh, S ;
Inoue, M ;
Harada, H ;
Hiraoka, M .
CANCER SCIENCE, 2003, 94 (12) :1021-1028
[10]   VITA BLUE - A NEW 633-NM EXCITABLE FLUORESCENT DYE FOR CELL ANALYSIS [J].
LEE, LG ;
BERRY, GM ;
CHEN, CH .
CYTOMETRY, 1989, 10 (02) :151-164